Scholarly Index
Jeffrey A. Engelman
Selecta Biosciences (United States); 84,250 total citations; 349 total publications; best world rank #14
Selecta Biosciences (United States)
84,250Total citations
349Total publications
132H-index
Published ranking records
| Field | Window | World rank | National rank | Impact score |
|---|---|---|---|---|
| Lung Cancer Treatments and Mutations | Lifetime | 35 | US 23 | 99.90 |
| Cancer Mechanisms and Therapy | Lifetime | 14 | US 8 | 99.61 |
| PI3K/AKT/mTOR signaling in cancer | Lifetime | 15 | US 9 | 99.79 |
| Caveolin-1 and cellular processes | Lifetime | 22 | US 15 | 98.68 |
| Lung Cancer Research Studies | Lifetime | 186 | US 96 | 99.22 |
| HER2/EGFR in Cancer Research | Lifetime | 189 | US 92 | 99.13 |
| Colorectal Cancer Treatments and Studies | Lifetime | 361 | US 166 | 98.88 |
| Cancer therapeutics and mechanisms | Lifetime | 295 | US 176 | 98.36 |
| Cancer Genomics and Diagnostics | Lifetime | 917 | US 475 | 98.40 |
| Melanoma and MAPK Pathways | Lifetime | 270 | US 143 | 97.15 |
| Metabolism, Diabetes, and Cancer | Lifetime | 746 | US 319 | 97.41 |
| Protein Kinase Regulation and GTPase Signaling | Lifetime | 489 | US 255 | 96.82 |
| Protein Tyrosine Phosphatases | Lifetime | 905 | US 331 | 86.04 |